Status:
COMPLETED
The Influence of Fish-oil Lipid Emulsions on Neonatal Morbidities
Lead Sponsor:
Dr. Sami Ulus Children's Hospital
Conditions:
Retinopathy of Prematurity
Neonatal Cholestasis
Eligibility:
All Genders
1-3 years
Phase:
NA
Brief Summary
Docosahexaenoic acid (DHA) has been shown to be particularly important for fetal and neonatal development. Infants born prematurely are at special risk for DHA insufficiency. The source of DHA after b...
Detailed Description
During the study period, preterm infants admitted to NICU were included. Infants who weighed \<1500 gr and delivered prematurely before the 32nd week of gestation were eligible for the study. Infants ...
Eligibility Criteria
Inclusion
- Infants below 32 gestational age and requiring parenteral nutrition
Exclusion
- Infants with congenital anomalies, infants above 32 gestational age
Key Trial Info
Start Date :
January 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2013
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT01875510
Start Date
January 1 2013
End Date
November 1 2013
Last Update
July 8 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dr. Sami Ulus Childrens Hospital
Ankara, Turkey (Türkiye), 06080